-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PXS-6302 in Burns
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PXS-6302 in Burns report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PXS-6302 in Burns Drug Details: PXS-6302 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PXS-6302 in Scar
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PXS-6302 in Scar report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PXS-6302 in Scar Drug Details: PXS-6302 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Albumin (Human) in Decompensated Cirrhosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Albumin (Human) in Decompensated Cirrhosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Albumin (Human) in Decompensated Cirrhosis Drug Details: Human Albumin (Albiomin, Albumin, Albutein, Plasbumin, Albuplan)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Siltuximab in Metastatic Adenocarcinoma of The Pancreas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Siltuximab in Metastatic Adenocarcinoma of The Pancreas report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Siltuximab in Metastatic Adenocarcinoma of The Pancreas Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Albumin (Human) in Hepatic Encephalopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Albumin (Human) in Hepatic Encephalopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Albumin (Human) in Hepatic Encephalopathy Drug Details: Human Albumin (Albiomin, Albumin, Albutein, Plasbumin, Albuplan)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mecasermin Rinfabate in Bronchopulmonary Dysplasia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mecasermin Rinfabate in Bronchopulmonary Dysplasia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mecasermin Rinfabate in Bronchopulmonary Dysplasia Drug Details: Mecasermin rinfabate (Iplex) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Albumin (Human) in Ascites
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Albumin (Human) in Ascites report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Albumin (Human) in Ascites Drug Details: Human Albumin (Albiomin, Albumin, Albutein, Plasbumin, Albuplan) is obtained...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sevoflurane in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sevoflurane in Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sevoflurane in Pain Drug Details: VPX-638 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MP-101 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MP-101 in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MP-101 in Parkinson's Disease Drug Details: MP-101 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MP-101 in Secondary Progressive Multiple Sclerosis (SPMS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MP-101 in Secondary Progressive Multiple Sclerosis (SPMS) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MP-101 in Secondary Progressive Multiple Sclerosis (SPMS) Drug Details:...